Animal Spirits: Life and Death – Go Health Pro

Animal Spirits: Life and Death – Go Health Pro

Today’s Animal Spirits is brought to you by YCharts and KraneShares: See here for 20% off your initial YCharts Professional subscription for new customers only See here for more information on KWEB Get a random Animal Spirits chart here  On today’s show, we discuss: Listen here Recommendations: Charts: Tweets/Bluesky: Roughly 275,000 federal workers lost their … Read more

Triple-I Blog | Executive Exchange: Insuring AI-Related Risks – Go Health Pro

Triple-I Blog | Executive Exchange: Insuring AI-Related Risks – Go Health Pro

By Lewis Nibbelin, Contributing Writer, Triple-I Garnering millions of weekly users and over a billion user messages every day, the generative AI chatbot ChatGPT became one of the fastest-growing consumer applications of all time, helping to lead the charge in AI’s transformation of business operations across various industries worldwide. With generative AI’s rise, however, came … Read more

Keeping Special Olympics Hawaii Athletes in the Game – Go Health Pro

Keeping Special Olympics Hawaii Athletes in the Game – Go Health Pro

Local athletes received medical exams at no cost at Kaiser Permanente Mapunapuna Medical Office during MedFest 2025 in February. The annual event is hosted by Kaiser Permanente in Hawaii in partnership with Special Olympics Hawaii. Now in its 15th year, MedFest provides comprehensive physical screenings to ensure athletes of all ages are prepared to train … Read more

A Shambles: Rinkoff v Baby Cow Productions; is the format of a show a protectable copyright work? – Go Health Pro

A Shambles: Rinkoff v Baby Cow Productions; is the format of a show a protectable copyright work? – Go Health Pro

Photo by Kevin Snow on Unsplash In a recent decision, the UK IPEC has considered whether the format of a comedy show can be protectable as a dramatic work in copyright. The claim was brought by Joshua Rinkoff (the “Claimant”) for copyright infringement of a comedy show he wrote, produced and acted in called “Shambles”. … Read more

Zacks Small Cap Research – BLRX: Aphexda Transition Progressing – Go Health Pro

Zacks Small Cap Research – BLRX: Aphexda Transition Progressing – Go Health Pro

By John Vandermosten, CFA NASDAQ:BLRX READ THE FULL BLRX RESEARCH REPORT BioLineRx Ltd. (NASDAQ:BLRX) continues its commercialization transition activities for Aphexda as responsibilities for marketing shift from BioLine’s internal team to Ayrmid’s subsidiary Gamida Cell. Gamida cell is commercializing Omisirge, a cell therapy for treating blood cancers in patients who need a stem cell transplant. … Read more

x